Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Minor UI and metadata updates: glossary display option added and footer text updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:42.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:37.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T10:36:20.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:25:34.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and related operating-status updates has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T19:16:32.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The update appears to show only minor layout adjustments with no changes to the core study content, such as design, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.